{ "items": [ "\n\n
Brooke Prakash is a Postdoctoral Research Assistant in the Department of Pharmacology. Here she discusses her project and benefits she has drawn from her experience so far as an Oxford-BMS Fellow.
\n \n\n \n \nCaitlin O'Brien-Ball is a Oxford-BMS Research Fellow in the CAMS Oxford Institute (Nuffield Department of Medicine). Here she discusses her project and benefits she has drawn from her experience so far as an Oxford-BMS Fellow.
\n \n\n \n \nDafni is a Translational Research Fellow in the Kennedy Institute of Rheumatology (Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences). Here she discusses her project and benefits she has drawn from her experience so far as an Oxford-BMS Fellow.
\n \n\n \n \nMaria discusses her project and benefits she has drawn from her experience so far as an Oxford-BMS Fellow.
\n \n\n \n \nRupen discusses his project and benefits he has drawn from his experience so far as an Oxford-BMS Fellow.
\n \n\n \n \nRanjeet discusses his project and benefits he has drawn from his experience so far as an Oxford-BMS Fellow.
\n \n\n \n \nNima is a Postdoctoral Research Fellow in Nuffield Department of Medicine. Here he discusses his project and benefits he has drawn from his experience so far as an Oxford-BMS Fellow.
\n \n\n \n \nMeet the Business Partnerships Office and find out how we can help you.
\n \n\n \n \nAn active alliance between Bristol Myers Squibb (BMS) and the University of Oxford aims to catalyse translational research that has the potential to make a difference to the lives of patients, and equip a cohort of researchers with an in-depth understanding of industry research and development.
\n \n\n \n \nAn active alliance between Bristol Myers Squibb (BMS) and the University of Oxford aims to catalyse translational research that has the potential to make a difference to the lives of patients, and equip a cohort of researchers with an in-depth understanding of industry research and development.
\n \n\n \n \nAn active alliance between Bristol Myers Squibb (BMS) and the University of Oxford aims to catalyse translational research that has the potential to make a difference to the lives of patients, and equip a cohort of researchers with an in-depth understanding of industry research and development.
\n \n\n \n \nAn active alliance between Bristol Myers Squibb (BMS) and the University of Oxford aims to catalyse translational research that has the potential to make a difference to the lives of patients, and equip a cohort of researchers with an in-depth understanding of industry research and development.
\n \n\n \n \nAn active alliance between Bristol Myers Squibb (BMS) and the University of Oxford aims to catalyse translational research that has the potential to make a difference to the lives of patients, and equip a cohort of researchers with an in-depth understanding of industry research and development.
\n \n\n \n \nAn active alliance between Bristol Myers Squibb (BMS) and the University of Oxford aims to catalyse translational research that has the potential to make a difference to the lives of patients, and equip a cohort of researchers with an in-depth understanding of industry research and development.
\n \n\n \n \n